Geron says disciplined spending supports revenue growth and profitability path
Geron reports revenue up 24% year-to-date, citing disciplined spending and deeper community penetration, plus earlier-line patient use. International expansion and a myelofibrosis trial are flagged as near-term priorities toward profitability.